Detecting Potential Safety Issues in Large Clinical or Observational Trials by Bayesian Screening When Event Counts Arise from Poisson Distributions

Author： Gould A. Lawrence  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.4, 2013-07, pp. : 829-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayesian Hierarchical Modeling for Detecting Safety Signals in Clinical Trials

By Amy Xia H.  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 1006-1029

Taylor & Francis Ltd

Access to resources Recommend Favorite

BayesWeb: A User-Friendly Platform for Exploratory Bayesian Analysis of Safety Signals from Small Clinical Trials

By Scott John A.  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 1030-1041

Taylor & Francis Ltd

Access to resources Recommend Favorite

Predicting Event Times in Clinical Trials When Treatment Arm Is Masked

By Mark Donovan J.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 343-356

Taylor & Francis Ltd

Access to resources Recommend Favorite

Managing Safety Information from Clinical Trials: CIOMS VI

By  

Reactions Weekly, Vol. 1, Iss. 1011, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical Trials

By Farlow Martin R.  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 577-585

Adis International

Access to resources Recommend Favorite